≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

DOID EFO Endpoint Browser

CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS

lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C96
  • Hospital discharge: ICD-9 — 202
  • Hospital discharge: ICD-8 — 202
  • Cause of death: ICD-10 — C96
  • Cause of death: ICD-9 — 202
  • Cause of death: ICD-8 — 202

2 out of 7 registries used, show all original rules.

314

4. Check minimum number of events

None

314

5. Include endpoints

None

314

6. Filter based on genotype QC (FinnGen only)

314

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Neoplasmata maligna alia et non specificata textus lymphatici, haematopoetici et cognati

Similar endpoints

↥

List of similar endpoints to Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 314 146 168
Unadjusted period prevalence (%) 0.06 0.05 0.07
Median age at first event (years) 55.73 53.03 58.08

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
289
Matched controls
2887
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
155.7
135
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
42.7
122.1
156
77
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
43.9
41
*
XW000
NOMESCO Finland
Bone marrow biopsy
14.7
41.7
73
65
L03AA02
ATC
filgrastim; parenteral
16.4
32.4
53
39
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
30.5
31.6
42
16
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.4
28.5
58
68
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
27.2
115
360
C96.2
ICD-10 Finland
Malignant mast cell tumour
+∞
25.4
24
*
WW500
NOMESCO Finland
Blood transfusion
11.7
24.4
46
46
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
23.9
24.1
34
16
20199
ICD-8 Finland
Hodgkin's disease
260.7
24.0
24
*
JN4BD
NOMESCO Finland
Extensive body CT
5.2
23.9
84
212
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.6
22.9
56
88
A04AA01
ATC
ondansetron; systemic, rectal
7.1
21.0
54
91
C96.7
ICD-10 Finland
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
20.0
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
28.4
19.5
26
10
Q82.2
ICD-10 Finland
Mastocytosis
107.1
18.8
20
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
202.6
18.8
19
*
R50.9
ICD-10 Finland
Fever, unspecified
4.2
17.7
75
222
ZX120
NOMESCO Finland
Intravenous
5.0
17.2
59
141
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
27.6
17.2
23
9
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
9.7
16.7
34
39
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
63.7
15.9
18
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
20.7
15.8
23
12
1XC02
NOMESCO Finland
NA
33.7
15.0
19
6
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
10.3
14.8
29
31
M04AA01
ATC
allopurinol; systemic
3.6
14.7
77
268
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
17.3
13.7
21
13
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.0
12.6
21
16
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
12.6
12
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
+∞
12.6
12
*
20293
ICD-8 Finland
Other neoplasms of lymphoid tissue, Neoplasma benignum sive NUD medullae osseae
+∞
12.6
12
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
12.6
12
*
A02BC02
ATC
pantoprazole; systemic
2.6
12.4
212
1484
N02AA05
ATC
oxycodone; systemic
3.1
12.0
73
280
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
15.5
12.0
19
13
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
11.8
58
191
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
67.8
11.7
13
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
24.1
11.7
16
7
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.1
11.1
30
54
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
62.4
10.7
12
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
114.0
10.5
11
*
2024A
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Leukaemic reticuloendotheliosis
+∞
10.5
10
*
H02AB02
ATC
dexamethasone; systemic
3.4
10.4
52
173
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
19.7
10.4
15
8
H02AB06
ATC
prednisolone; systemic
2.2
9.8
159
1027
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
9.8
61
235
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
22.6
9.4
13
6
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
9.4
9
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
9.4
9
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
14.3
9.3
15
11
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
16.9
8.6
13
8
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
34.4
8.1
10
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
22.8
8.1
11
5
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
19.0
7.7
11
6
JN6AD
NOMESCO Finland
CT of torso and neck
12.3
7.7
13
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
7.6
79
406
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
7.6
149
1003
9741/3-C42.1
ICD-O-3
Malignant mastocytosis of bone marrow
82.1
7.5
8
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
82.1
7.5
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.1
7.3
22
46
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
7.3
7
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
30.8
7.2
9
*
B01AB05
ATC
enoxaparin; parenteral
2.1
7.0
102
603
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
6.9
64
307
JN4AD
NOMESCO Finland
Body CT examination
3.1
6.9
38
134
L03AA13
ATC
pegfilgrastim; parenteral
4.9
6.9
21
45
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
6.6
104
633
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
6.5
31
100
ZX090
NOMESCO Finland
Other technic of radiotherapy
5.4
6.4
18
35
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.3
6.3
14
20
2029X
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
+∞
6.3
6
*
C96.1
ICD-10 Finland
Malignant histiocytosis
+∞
6.3
6
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
6.3
6
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
6.3
6
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
27.3
6.3
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
6.5
6.2
15
24
WX892
NOMESCO Finland
Monitored bed care
2.9
6.1
36
136

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
60
24
30.67
87.63
1.4
1.2
—
—
—
0
0
64
34
23.39
83.62
1.5
1.2
—
—
—
0
0
106
159
9.55
72.53
1.3
1.4
—
—
—
0
0
126
254
7.62
65.61
1.4
1.5
—
—
—
0
0
58
57
12.25
53.60
1.6
1.8
—
—
—
0
0
123
297
6.16
51.92
1.5
1.5
—
—
—
0
0
129
353
5.51
46.69
1.6
1.9
—
—
—
0
0
206
836
5.26
45.56
10.4
5.6
—
—
—
0
0
102
241
5.79
43.30
1.8
1.4
—
—
—
0
0
237
1175
5.15
38.02
11.1
5.8
2.8
2.8
%
0.08
229
1098
237
1182
5.10
37.53
11.3
6.2
9.6
8.8
%
2.14
230
1111
232
1139
4.97
37.50
11.1
5.9
0.7
0.6
%
0.28
225
1063
55
81
8.02
36.92
4.6
4.0
47.3
29.5
mg/l
1.03
46
64
238
1211
4.99
36.15
11.1
6.0
27.3
27.1
%
0.08
231
1124
54
81
7.84
35.63
4.6
4.0
55.0
138.6
mg/l
0.52
45
64
241
1260
4.93
34.71
10.2
5.6
0.6
0.6
e9/l
0.94
216
1077
234
1199
4.74
34.59
10.4
5.7
55.5
57.7
%
1.50
226
1121
241
1270
4.86
34.07
10.2
5.6
0.0
0.0
e9/l
0.14
216
1090
245
1310
4.96
33.88
10.9
5.9
0.2
0.2
e9/l
0.61
225
1151
81
194
5.28
33.16
4.6
2.6
9.9
10.3
g/l
0.19
76
181
242
1295
4.79
33.09
10.3
5.7
2.0
1.9
e9/l
0.11
227
1141
78
182
5.37
32.89
3.3
2.5
—
—
—
0
0
165
681
4.00
32.74
5.7
2.7
335.9
6975.4
umol/l
2.87
158
577
107
328
4.43
32.16
3.5
2.8
1.7
1.8
%
1.17
101
292
38
42
10.16
31.90
1.5
1.3
—
—
—
0
0
255
1480
4.85
29.66
22.1
9.4
4.1
4.2
e9/l
0.08
239
1299
219
1148
4.00
29.40
9.2
4.8
33.6
35.2
g/l
3.57
213
1065
132
507
3.77
28.34
6.4
3.0
2.5
2.5
mmol/l
3.72
125
445
115
413
3.82
27.12
5.9
3.3
0.8
0.8
mmol/l
0.24
109
385
82
236
4.35
26.30
4.3
3.0
67.8
70.9
e9/l
0.26
61
181
239
1390
4.01
26.08
12.9
6.5
10.6
12.1
umol/l
1.48
234
1314
31
35
9.72
25.49
1.5
1.2
237.1
333.4
u/ml
0.48
20
19
27
25
11.72
25.45
2.6
1.7
1.4
1.2
e9/l
0.30
21
14
20
11
19.35
24.92
3.1
1.5
3304.2
821.8
u/ml
1.30
20
11
23
17
14.52
24.77
2.0
1.8
16.8
10.3
%
—
10
8
38
58
7.32
24.42
5.2
4.7
—
—
—
0
0
39
62
7.04
24.15
1.6
1.2
—
—
—
0
0
23
18
13.71
23.97
2.7
1.8
387.8
741.9
e6/l
—
5
8
165
798
3.25
23.51
8.4
3.8
7.4
7.4
ph
0.03
37
144
141
636
3.21
22.39
18.4
6.7
—
—
—
0
0
208
1199
3.18
21.05
10.9
6.2
1.2
1.2
mmol/l
0.04
203
1077
170
880
3.03
20.79
7.8
3.4
2.4
2.4
mmol/l
0.02
156
759
219
1307
3.23
20.71
11.8
7.2
1.2
1.2
mmol/l
0.57
185
1111
99
377
3.37
20.61
2.4
2.3
21.3
22.6
%
0.37
90
329
102
398
3.31
20.38
2.3
2.3
2.2
2.3
g/l
1.60
96
368
153
771
2.92
19.28
7.9
4.7
—
—
—
0
0
105
437
3.11
18.59
2.4
2.3
11.8
13.0
umol/l
0.78
100
402
48
119
4.58
18.32
2.0
2.2
1.4
1.5
g/l
0.24
39
103
191
1103
2.87
18.29
17.8
10.1
0.0
0.0
e9/l
0.61
166
886
66
216
3.60
17.16
8.2
4.5
1.0
1.0
%
0.07
41
74
32
60
5.83
16.74
2.0
1.8
—
—
—
0
0
61
199
3.56
15.87
8.6
4.7
0.4
0.2
%
0.56
37
65
60
194
3.59
15.82
8.2
4.6
0.8
0.3
%
0.96
32
51
133
701
2.56
14.34
3.7
3.1
—
—
—
0
0
78
313
2.99
14.34
4.6
2.9
8.3
9.2
umol/l
0.18
72
275
173
1034
2.50
14.18
3.8
2.6
373.8
146.9
ug/l
2.68
165
938
135
735
2.47
13.38
3.9
3.2
0.4
0.5
e6/l
0.25
110
554
125
667
2.45
12.84
2.1
2.0
3.1
3.1
mg/l
0.07
108
566
141
801
2.38
12.51
3.9
3.3
45.6
149.6
e6/l
0.67
117
623
59
218
3.10
12.41
7.6
7.0
11.6
10.0
mmol/l
0.63
54
205
20
32
6.61
12.16
1.3
1.1
—
—
—
0
0
53
188
3.19
11.93
7.8
4.8
0.0
0.2
%
0.49
32
55
33
85
4.22
11.89
2.9
2.4
21.8
22.0
s
0.04
33
78
17
24
7.43
11.53
1.1
1.3
—
—
—
0
0
260
1989
2.79
11.09
18.7
7.7
91.6
79.6
u/l
2.65
254
1851
249
1866
2.62
11.07
6.7
4.1
18.0
12.7
mm/h
3.87
239
1697
105
552
2.36
10.84
2.2
1.8
3.3
1.3
mg/l
0.60
85
437
60
248
2.75
10.22
4.4
4.0
2.0
2.0
mmol/l
0.01
46
194
93
480
2.33
9.89
2.6
1.4
2.3
2.6
g/l
0.41
66
288
148
922
2.14
9.89
4.7
3.8
431.8
94.6
e6/l
0.39
118
666
178
1196
2.13
9.69
5.6
4.4
—
—
—
0
0
55
224
2.76
9.61
7.8
8.3
—
—
—
0
0
14
20
7.28
9.36
2.8
2.5
—
—
—
0
0
136
835
2.11
9.30
4.4
2.5
—
—
—
0
0
97
526
2.22
9.07
4.5
3.4
280.5
213.6
ng/l
0.15
79
434
167
1120
2.05
8.86
12.2
10.2
1.3
1.3
inr
0.28
43
310
36
121
3.23
8.79
2.2
3.6
488.5
1516.2
u/ml
0.42
25
104
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
18
36
5.24
8.72
1.4
1.5
—
—
—
0
0
79
400
2.30
8.67
1.8
2.1
—
—
—
0
0
13
8
16.87
8.62
2.2
1.5
—
—
—
0
0
13
8
16.87
8.62
1.2
1.0
—
—
—
0
0
13
19
7.09
8.51
1.5
1.3
—
—
—
0
0
211
1559
2.08
8.37
7.4
5.1
6.6
6.8
mmol/l
0.53
202
1459
152
1000
2.01
8.37
2.7
2.1
—
—
—
0
0
100
569
2.11
8.16
3.1
2.6
5.3
4.9
e6/l
0.08
92
497
96
539
2.13
8.11
3.3
2.8
499.1
569.7
mosm/kgh2o
3.06
88
449
17
35
5.08
7.98
1.1
1.0
—
—
—
0
0
95
539
2.09
7.76
9.5
5.1
—
—
—
0
0
157
1066
1.95
7.69
2.1
2.0
87.9
92.8
pmol/l
0.64
94
548
19
48
4.15
7.00
4.3
3.7
52.4
58.1
%
0.71
19
48
66
340
2.19
6.83
8.0
7.2
104.3
104.1
mmol/l
0.07
66
335
16
36
4.63
6.79
1.1
1.1
—
—
—
0
0
33
126
2.81
6.46
1.3
1.2
451.1
202.4
u/ml
0.64
27
110
104
645
1.92
6.44
1.4
1.5
18.7
20.8
nmol/l
0.84
91
536
43
194
2.41
6.03
4.0
3.8
76.5
81.9
ng/l
0.18
38
170
58
301
2.14
5.85
1.6
1.3
1260.0
557.7
titre
0.68
12
70
87
523
1.92
5.84
1.8
1.7
995.9
1211.7
nmol/l
1.86
70
383
13
28
4.80
5.79
3.1
2.4
—
—
—
0
0
16
41
4.06
5.79
1.1
1.7
—
—
—
0
0
17
46
3.85
5.72
4.2
3.0
3.3
4.6
e9/l
2.01
17
46
123
831
1.79
5.66
2.7
2.6
49.9
56.5
u/l
1.46
108
768
58
307
2.09
5.55
2.6
4.4
45.7
45.1
ug/l
0.00
45
260
99
630
1.83
5.53
1.5
1.4
—
—
—
0
0
18
53
3.54
5.39
1.2
1.5
12.9
9.1
e6/l
0.13
12
41
18
53
3.54
5.39
1.2
1.6
8.8
219.6
e6/l
1.03
13
42
11
23
4.92
5.05
1.2
1.3
—
—
—
0
0
11
23
4.92
5.05
1.1
1.1
—
—
—
0
0
15
41
3.79
4.98
1.1
1.1
—
—
—
0
0
55
303
1.99
4.70
1.7
1.8
—
—
—
0
0
217
1782
1.70
4.51
5.1
4.1
—
—
—
0
0
19
66
3.00
4.41
1.2
1.2
—
—
—
0
0
13
36
3.72
4.25
4.6
2.6
—
—
—
0
0
10
23
4.46
4.12
1.0
2.1
—
—
—
0
0
7
7
10.19
4.03
2.9
3.1
—
—
—
0
0
18
66
2.83
3.82
1.4
1.3
—
—
—
0
0
20
78
2.67
3.80
3.2
3.7
—
—
—
0
0
9
17
5.42
3.53
1.0
1.1
—
—
—
0
0
53
320
1.79
3.41
1.4
1.3
—
—
—
0
0
59
371
1.73
3.30
35.3
25.0
1.1
1.3
inr
—
5
48
9
19
4.84
3.26
1.0
1.8
—
—
—
0
0
7
11
6.48
3.20
2.1
1.5
—
—
—
0
0
55
346
1.71
3.07
1.5
1.3
—
—
—
0
0
23
108
2.22
2.99
1.2
1.2
—
—
—
0
0
13
46
2.90
2.95
1.2
2.0
—
—
—
0
0
37
209
1.87
2.94
4.7
3.7
—
—
—
0
0
10
30
3.41
2.93
1.9
1.5
89.1
89.9
%
—
10
30
6
9
6.77
2.88
2.8
1.4
—
—
—
0
0
19
84
2.34
2.83
1.2
1.2
—
—
—
0
0
16
66
2.50
2.75
4.5
3.0
7.4
7.4
ph
0.42
16
57
11
37
3.04
2.72
1.4
1.7
—
—
—
0
0
202
1731
1.47
2.67
5.3
4.5
—
—
—
0
0
10
32
3.19
2.67
1.4
1.5
—
—
—
0
0
5
7
7.24
2.56
1.0
1.1
—
—
—
0
0
10
33
3.10
2.55
8.7
4.2
—
—
—
0
0
107
820
1.46
2.52
3.6
3.3
—
—
—
0
0
56
804
0.63
2.52
3.2
3.0
—
—
—
0
0
8
21
3.88
2.48
2.0
2.0
—
—
—
0
0
7
17
4.19
2.37
1.4
1.9
—
—
—
0
0
244
2204
1.48
2.20
34.1
16.8
37.2
39.6
%
4.37
179
1507
89
681
1.43
2.07
5.5
4.2
0.0
0.0
estimate
0.00
38
225
271
2513
1.57
2.04
36.1
15.8
27.4
24.4
mg/l
0.93
250
2036
26
149
1.81
2.02
1.3
1.8
—
—
—
0
0
24
135
1.84
1.97
1.3
1.3
—
—
—
0
0
7
21
3.38
1.97
3.6
2.1
—
—
—
0
0
128
1051
1.37
1.95
4.6
4.0
28.2
41.2
ng/l
1.17
96
782
46
313
1.55
1.90
8.2
9.2
0.9
1.2
mmol/l
0.26
39
250
7
22
3.23
1.89
1.6
1.5
—
—
—
0
0
5
12
4.22
1.83
1.4
3.3
107.0
60.6
nmol/l
—
5
12
7
23
3.09
1.81
1.4
1.7
—
—
—
0
0
224
2433
0.72
1.78
4.3
4.6
1.3
1.5
mmol/l
4.61
201
2207
14
69
2.08
1.67
9.6
2.9
2.1
1.6
mg/l
0.56
14
62
233
2506
0.73
1.63
4.9
5.2
2.5
2.7
mmol/l
1.62
206
2270
227
2451
0.73
1.63
4.4
4.7
4.3
4.6
mmol/l
2.63
207
2242
5
14
3.61
1.62
1.8
1.9
—
—
—
0
0
42
291
1.51
1.61
8.7
9.5
95.6
95.5
%
0.01
42
281
8
32
2.54
1.61
1.4
2.6
3.8
2.6
nmol/l
—
8
32
206
1851
1.33
1.59
4.3
3.7
15.0
14.9
pmol/l
0.15
187
1634
7
26
2.73
1.59
2.4
2.0
—
—
—
0
0
6
20
3.04
1.59
1.0
1.0
—
—
—
0
0
216
2344
0.75
1.55
5.9
6.1
40.4
40.4
mmol/mol
0.01
190
2154
67
514
1.39
1.52
1.2
1.2
0.5
1.4
u/ml
1.32
14
132
19
109
1.79
1.50
4.2
4.1
—
—
—
0
0
23
141
1.68
1.46
12.0
13.0
—
—
—
0
0
38
264
1.50
1.45
9.5
10.1
118.0
120.1
g/l
0.26
38
256
141
1216
1.29
1.42
5.0
3.8
0.0
0.0
estimate
0.00
40
234
7
29
2.45
1.40
1.0
1.1
—
—
—
0
0
12
60
2.04
1.40
1.2
1.1
—
—
—
0
0
9
42
2.18
1.35
3.0
2.7
—
—
—
0
0
18
106
1.74
1.32
7.7
9.7
0.8
0.9
%
0.83
18
98
8
34
2.39
1.30
1.5
1.4
—
—
—
0
0
96
799
1.29
1.25
2.1
2.1
154.9
226.1
u/l
0.57
91
750
18
108
1.71
1.25
7.7
9.5
1.5
1.6
%
0.24
18
100
142
1244
1.26
1.21
5.0
3.9
0.0
0.0
estimate
0.00
40
219
8
38
2.13
1.19
1.5
1.3
—
—
—
0
0
6
26
2.33
1.19
1.3
1.0
—
—
—
0
0
11
57
1.96
1.18
3.5
4.8
—
—
—
0
0
220
2354
0.78
1.18
4.2
4.2
1.3
1.3
mmol/l
0.86
195
2127
140
1228
1.25
1.17
6.5
5.2
0.0
0.0
estimate
0.00
41
229
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
10
179
0.54
1.09
1.5
1.4
—
—
—
0
0
34
248
1.42
1.05
2.0
2.6
2.8
6.5
ug/l
2.59
29
220
27
189
1.47
1.03
6.3
6.9
—
—
—
0
0
48
373
1.34
1.02
1.2
1.3
3.7
14.2
u/ml
1.56
14
138
10
173
0.56
0.98
2.8
3.1
—
—
—
0
0
274
2624
1.35
0.98
35.6
18.4
139.3
139.7
mmol/l
2.12
268
2553
25
175
1.47
0.96
3.0
2.7
3.7
4.0
e9/l
0.22
20
130
6
27
2.25
0.94
1.2
1.1
—
—
—
0
0
274
2628
1.33
0.93
36.8
18.5
4.0
4.0
mmol/l
0.48
268
2556
23
160
1.47
0.92
2.0
2.4
—
15.7
—
0
6
6
30
2.02
0.87
1.3
1.3
—
—
—
0
0
277
2666
1.33
0.87
22.0
10.8
25.9
25.6
u/l
0.14
271
2561
41
320
1.32
0.86
1.9
1.5
—
—
—
0
0
8
47
1.72
0.81
1.5
3.6
55.8
64.3
%
—
8
47
79
677
1.22
0.79
4.0
3.5
—
—
—
0
0
8
48
1.68
0.79
2.4
2.4
—
—
—
0
0
107
947
1.20
0.77
5.0
3.7
—
—
—
0
0
24
178
1.38
0.71
9.4
9.5
25.2
24.4
mmol/l
0.61
24
168
10
61
1.66
0.69
6.8
2.7
—
—
—
0
0
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
30
234
1.31
0.66
1.8
1.5
—
—
—
0
0
23
173
1.36
0.64
1.2
1.2
—
—
—
0
0
24
183
1.34
0.61
1.3
1.4
—
—
—
0
0
13
89
1.48
0.59
2.9
3.4
0.1
0.2
g/l
—
8
33
18
132
1.39
0.58
1.7
2.8
—
—
—
0
0
64
557
1.19
0.56
5.8
4.0
—
—
—
0
0
6
37
1.63
0.56
1.5
1.5
—
—
—
0
0
9
60
1.51
0.55
12.6
14.1
9.9
11.1
mmol/l
—
9
54
9
60
1.51
0.55
12.6
14.1
104.0
105.4
mmol/l
—
9
54
36
297
1.24
0.53
1.4
1.3
—
—
—
0
0
48
410
1.20
0.51
1.2
1.3
39.2
35.6
iu/ml
0.05
13
122
237
2284
1.15
0.48
5.3
4.5
2.0
2.0
mu/l
0.17
219
2047
19
146
1.32
0.48
2.6
3.1
0.5
0.2
e6/l
0.43
19
141
5
31
1.62
0.43
2.4
3.1
—
—
—
0
0
12
87
1.39
0.43
4.1
3.6
4.0
3.9
mmol/l
0.26
12
82
8
59
1.37
0.41
2.1
1.7
2754.9
18958.0
e6/l
—
8
45
0
16
0.00
0.41
0.0
3.0
—
32.7
—
0
10
10
71
1.42
0.39
1.5
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.4
—
—
—
0
0
12
89
1.36
0.38
1.0
1.1
—
—
—
0
0
62
557
1.14
0.38
1.7
1.8
469.5
438.2
pmol/l
0.39
50
446
8
112
0.71
0.38
2.1
1.5
—
—
—
0
0
7
57
1.23
0.29
1.1
1.5
253.6
262.8
mu/l
—
7
50
20
236
0.84
0.27
1.8
1.6
—
—
—
0
0
16
133
1.21
0.24
2.6
2.4
—
—
—
0
0
71
665
1.09
0.22
1.5
1.7
1.4
1.3
mmol/l
0.21
60
541
0
11
0.00
0.21
0.0
8.5
—
0.6
—
0
11
0
10
0.00
0.21
0.0
1.1
—
2.6
—
0
10
0
12
0.00
0.21
0.0
14.7
—
1760.3
—
0
12
0
12
0.00
0.21
0.0
1.7
—
0.8
—
0
7
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
4.6
—
0
7
86
817
1.07
0.19
3.1
3.1
7.1
7.4
mmol/l
0.27
66
670
11
91
1.22
0.18
1.9
1.6
—
—
—
0
0
11
131
0.83
0.17
4.8
3.9
—
—
—
0
0
8
71
1.13
0.16
30.1
2.9
7.8
7.9
kpa
—
8
64
58
547
1.07
0.16
5.4
4.4
1.0
1.0
kg/l
—
5
83
6
78
0.76
0.15
6.0
4.4
—
—
—
0
0
75
781
0.95
0.12
3.4
3.3
36.0
207.7
mg/l
0.91
49
520
28
259
1.09
0.12
5.6
4.2
—
—
—
0
0
55
573
0.95
0.09
3.1
3.0
0.6
0.8
ug/l
1.78
42
383
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
6
56
1.07
0.08
6.0
2.5
—
—
—
0
0
80
823
0.96
0.08
3.8
4.0
5.5
7.7
mg/mmol
0.74
53
527
13
143
0.91
0.07
1.5
1.2
—
—
—
0
0
20
186
1.08
0.07
15.2
3.7
5.1
5.1
kpa
0.07
20
173
11
99
1.12
0.06
1.5
1.9
—
—
—
0
0
79
804
0.98
0.04
5.2
4.1
—
—
—
0
0
278
2770
1.03
0.03
47.0
22.9
234.9
243.3
e9/l
0.90
268
2698
24
231
1.04
0.03
5.6
3.6
—
—
—
0
0
246
2449
1.02
0.03
4.7
4.8
6.0
6.0
mmol/l
0.09
224
2210
278
2771
1.03
0.02
47.0
22.9
4.2
4.5
e12/l
12.87
267
2689
278
2772
1.03
0.01
47.1
22.9
7.8
6.7
e9/l
1.12
266
2691
261
2611
1.00
0.00
24.2
14.8
—
—
—
0
0
18
175
1.03
0.00
1.4
1.5
—
—
—
0
0
100
1004
0.99
0.00
4.7
5.1
4.1
2.2
ug/l
0.49
93
891
29
295
0.98
0.00
2.8
2.3
156.8
124.6
ug/g
0.13
23
226
13
134
0.97
0.00
19.7
3.9
—
—
—
0
0
8
82
0.97
0.00
1.3
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
7
79
0.88
0.00
1.6
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
19.4
—
0
7
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
2654.1
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS – Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).